Gastrointestinal side effects are by far the most prevalent during early treatment: Nausea Very common (may affect more than 1 in 10 people), typically peaking during the first week and often improving over two to four weeks [1] [2] Vomiting Common (may affect up to 1 in 10 people), usually occurring alongside nausea [1] [2] Diarrhoea Common, may persist for several weeks Constipation Common, sometimes alternating with diarrhoea Abdominal pain or discomfort Common, ranging from mild cramping to more pronounced discomfort Dyspepsia (indigestion) Common Eructation (belching) Common Reduced appetite A therapeutic effect that may feel uncomfortable initially, affecting eating patterns These symptoms arise because semaglutide mimics the natural GLP-1 hormone, which slows gastric emptying and increases satiety
Focus on Semaglutide 2.4 mg/week for the Treatment of Metabolic DysfunctionAssociated Steatohepatitis
Loosening the criteria for weight-loss drug access in the Medicaid program could end up costing the state more money, however
[1] Targeting the reward centre in your brain to reduce your appetite
AND TIRZEPATIDE SEMAGLUTIDE Tirzepatide, a promising injectable medication, is revolutionizing weight loss strategies
